Literature DB >> 19619884

Clinical and biochemical diagnosis of small-vessel disease in acute ischemic stroke.

Raf Brouns1, Jan Van Den Bossche, Didier De Surgeloose, Rishi Sheorajpanday, Peter P De Deyn.   

Abstract

BACKGROUND AND
PURPOSE: Both from clinical and research standpoints, it may be highly relevant to differentiate between small-artery and large-artery infarction in the acute phase of ischemic stroke. We conducted a study on the added value of two D-dimer assays over clinical assessment for diagnosis of lacunar infarction.
METHODS: Clinical evaluation using the Oxfordshire Community Stroke Project (OCSP) classification and measurement of plasma D-dimer levels by the VIDAS D-dimer test (VIDAS) and the Triage Stroke Panel (TSP) were performed in 128 patients with ischemic stroke presenting within 9 h after onset of symptoms. The stroke subtype was defined as small-artery or large-artery infarction based on the TOAST classification.
RESULTS: The overall accuracy for diagnosing of acute lacunar stroke using the OCSP classification, VIDAS (cut point for D-dimer 445 ng/mL) or TSP (cut point 300 ng/mL) was 89%, 88% and 87% respectively (P<0.001). The conjunctive use of the OCSP classification and VIDAS or TSP improved the accuracy to 97% and 98% respectively (P<0.001). The kappa coefficient for agreement between the two assays was acceptable (kappa, 0.64). These results were reproducible in subgroups of patients presenting within 4.5 h and within 6 h after onset of stroke symptoms.
CONCLUSIONS: Diagnosis of acute lacunar infarction can reliably be made, based on the conjunctive use of clinical evaluation and measurement of D-dimer levels either by a standard assay or by a bedside testing kit.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19619884     DOI: 10.1016/j.jns.2009.06.032

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  7 in total

1.  The relationship between plasma D-dimer levels and outcome of Chinese acute ischemic stroke patients in different stroke subtypes.

Authors:  Wei Yuan; Zheng-Hong Shi
Journal:  J Neural Transm (Vienna)       Date:  2013-11-08       Impact factor: 3.575

2.  The role of tryptophan catabolism along the kynurenine pathway in acute ischemic stroke.

Authors:  Raf Brouns; Robert Verkerk; Tony Aerts; Didier De Surgeloose; Annick Wauters; Simon Scharpé; Peter P De Deyn
Journal:  Neurochem Res       Date:  2010-05-19       Impact factor: 3.996

3.  Malignant Isolated Cortical Vein Thrombosis as the Initial Manifestation of Primary Antiphospholipid Syndrome: Lessons on Diagnosis and Management From a Case Report.

Authors:  Jie Shen; Zi Tao; Wei Chen; Jing Sun; Yan Li; Fangwang Fu
Journal:  Front Immunol       Date:  2022-04-25       Impact factor: 8.786

4.  Clinical symptoms and risk factors in cerebral microangiopathy patients.

Authors:  Sandra Okroglic; Catherine N Widmann; Horst Urbach; Philip Scheltens; Michael T Heneka
Journal:  PLoS One       Date:  2013-02-05       Impact factor: 3.240

Review 5.  The Potential Impact of Neuroimaging and Translational Research on the Clinical Management of Lacunar Stroke.

Authors:  Salvatore Rudilosso; Alejandro Rodríguez-Vázquez; Xabier Urra; Adrià Arboix
Journal:  Int J Mol Sci       Date:  2022-01-28       Impact factor: 5.923

6.  Plasma D-dimer levels are associated with stroke subtypes and infarction volume in patients with acute ischemic stroke.

Authors:  Wen-Jie Zi; Jie Shuai
Journal:  PLoS One       Date:  2014-01-20       Impact factor: 3.240

7.  A Novel Combination of Blood Biomarkers and Clinical Stroke Scales Facilitates Detection of Large Vessel Occlusion Ischemic Strokes.

Authors:  Edoardo Gaude; Barbara Nogueira; Marcos Ladreda Mochales; Sheila Graham; Sarah Smith; Lisa Shaw; Sara Graziadio; Gonzalo Ladreda Mochales; Philip Sloan; Joshua D Bernstock; Shashank Shekhar; Toby I Gropen; Christopher I Price
Journal:  Diagnostics (Basel)       Date:  2021-06-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.